Genome-wide methylation profiling of early colorectal cancer using an Illumina Infinium Methylation EPIC BeadChip

Table 1 Patient characteristics

	Gender	Age	Group	TNM stage
C1	Male	52	CRC (I)	I
C2	Male	62	CRC (I)	I
C3	Female	62	CRC (I)	I
C4	Male	64	CRC (I)	I
C5	Female	79	CRC (I)	I
A1	Female	69	Adenoma
A2	Male	69	Adenoma
A3	Male	69	Adenoma
A4	Male	49	Adenoma
A5	Male	74	Adenoma

CRC: Colorectal cancer; TNM: Tumor-node-metastasis.

Table 2 The distribution of differentially methylated sites, (n)

Chromosome	DMSs	Hypermethylated	Hypomethylated
chr1	162	62	100
chr2	158	53	105
chr3	104	35	69
chr4	83	22	61
chr5	112	35	77
chr6	112	25	87
chr7	115	55	60
chr8	89	27	62
chr9	79	33	46
chr10	91	29	62
chr11	104	42	62
chr12	105	41	64
chr13	53	18	35
chr14	50	22	28
chr15	58	22	36
chr16	72	34	38
chr17	76	35	41
chr18	38	13	25
chr19	88	33	55
chr20	60	22	38
chr21	25	7	18
chr22	31	11	20

DMSs: Differentially methylated sites.